These studies focused on GBM, the most malignant glioma, presented IGFBP5 was an oncogene, which was in line with our results that IGFBP5 was significantly higher in GBM patients and hypoxia GBM cell lines than control, showing sensitivity in prediction of GBM prognosis. This evidence concerns the gene IGFBP5 and glioma.